$3.27
+0.10 (+3.15%)
LNAI News2 articles
Lunai Bioworks Patent Deal Boosts Nasdaq Compliance Bid
Lunai Bioworks completed a $20 million patent acquisition via preferred stock, bolstering its Nasdaq listing compliance. Shares remain under $1.
Lunai Bioworks Shares Surge on Nasdaq Compliance Filing
Lunai Bioworks shares surged 80.88% after hours to $5.15 after Nasdaq confirmed compliance with the $1 minimum bid-price rule, averting delisting risk, though the company remains under a one-year panel monitor and has expressed substantial doubt about its ability to continue operations.